Abstract:BACKGROUND:Natural articular cartilage has a limited capacity for spontaneous regeneration. Controlled release of transforming growth factor-beta1 (TGF-beta1) to cartilage defects can enhance chondrogenesis. In this study, we assessed the feasibility of using biodegradable chitosan microspheres as carriers for controlled TGF-beta1 delivery and the effect of released TGF-beta1 on the chondrogenic potential of chondrocytes.METHODS:Chitosan scaffolds and chitosan microspheres loaded with TGF-beta1 were prepared by the freeze-drying and the emulsion-crosslinking method respectively. In vitro drug release kinetics, as measured by enzyme-linked immunosorbent assay, was monitored for 7 days. Lysozyme degradation was performed for 4 weeks to detect in vitro degradability of the scaffolds and the microspheres. Rabbit chondrocytes were seeded on the scaffolds containing TGF-beta1 microspheres and incubated in vitro for 3 weeks. Histological examination and type II collagen immunohistochemical staining was performed to evaluate the effects of released TGF-beta1 on cell adhesivity, proliferation and synthesis of the extracellular matrix.RESULTS:TGF-beta1 was encapsulated into chitosan microspheres and the encapsulation efficiency of TGF-beta1 was high (90.1%). During 4 weeks of incubation in lysozyme solution for in vitro degradation, the mass of both the scaffolds and the microspheres decreased continuously and significant morphological changes was noticed. From the release experiments, it was found that TGF-beta1 could be released from the microspheres in a multiphasic fashion including an initial burst phase, a slow linear release phase and a plateau phase. The release amount of TGF-beta1 was 37.4%, 50.7%, 61.3%, and 63.5% for 1, 3, 5, and 7 days respectively. At 21 days after cultivation, type II collagen immunohistochemical staining was performed. The mean percentage of positive cells for collagen type II in control group (32.7% +/- 10.4%) was significantly lower than that in the controlled TGF-beta1 release group (92.4% +/- 4.8%, P < 0.05). Both the proliferation rate and production of collagen type II in the transforming growth factor-beta1 microsphere incorporated scaffolds were significantly higher than those in the scaffolds without microspheres, indicating that the activity of TGF-beta1 was retained during microsphere fabrication and after growth factor release.CONCLUSION:Chitosan microspheres can serve as delivery vehicles for controlled release of TGF-beta1, and the released growth factor can augment chondrocytes proliferation and synthesis of extracellular matrix. Chitosan scaffolds incorporated with chitosan microspheres loaded with TGF-beta1 possess a promising potential to be applied for controlled cytokine delivery and cartilage tissue engineering.

Porous Nano-Ha/collagen/plla Scaffold Containing Chitosan Microspheres for Controlled Delivery of Synthetic Peptide Derived from BMP-2.

In Vitro Degradation and Release Behavior of Porous Poly(lactic Acid) Scaffolds Containing Chitosan Microspheres As a Carrier for BMP-2-derived Synthetic Peptide

Repair of Bone Defect in Femoral Condyle Using Microencapsulated Chitosan, Nanohydroxyapatite/Collagen and Poly(L-Lactide)-Based Microsphere-Scaffold Delivery System

Porous deproteinized bovine bone scaffold with three-dimensional localized drug delivery system using chitosan microspheres

Synthesis and Characterization of Polyphosphazene Microspheres Incorporating Demineralized Bone Matrix Scaffolds Controlled Release of Growth Factor for Chondrogenesis Applications

Fabrication and Characterization of PLGA/HAp Composite Scaffolds for Delivery of BMP-2 Plasmid DNA.

Three-Dimensional Fibrous Plga/Hap Composite Scaffold for Bmp-2 Delivery

Preparation and characterization of chitosan microspheres for controlled release of synthetic oligopeptide derived from BMP-2.

Controlled Release of BMP-2 from a Collagen-Mimetic Peptide-Modified Silk Fibroin-Nanohydroxyapatite Scaffold for Bone Regeneration.

Preparation and Bioactivities of Plga/Nano-Hydroxyapatite Scaffold Containing Chitosan Microspheres for Controlled Delivery of Mutifuncational Peptide-Adrenomedullin

Chitosan/Nhac/Plga Microsphere Vehicle for Sustained Release of Rhbmp-2 and Its Derived Synthetic Oligopeptide for Bone Regeneration

The Enhancement of Osteogenesis by Nano-Fibrous Scaffolds Incorporating Rhbmp-7 Nanospheres.

Enhanced Osteogenesis of Multilayered Pore-Closed Microsphere-Immobilized Hydroxyapatite Scaffold Via Sequential Delivery of Osteogenic Growth Peptide and BMP-2

Chitosan/biphasic Calcium Phosphate Scaffolds Functionalized with BMP-2-encapsulated Nanoparticles and RGD for Bone Regeneration.

Zero-order controlled release of BMP2-derived peptide P24 from the chitosan scaffold by chemical grafting modification technique for promotion of osteogenesis in vitro and enhancement of bone repair in vivo

Macroporous Poly (L-Lactic Acid)/chitosan Nanofibrous Scaffolds Through Cloud Point Thermally Induced Phase Separation for Enhanced Bone Regeneration

Hollow hydroxyapatite microspheres/chitosan composite as a sustained delivery vehicle for rhBMP-2 in the treatment of bone defects

Calcium sulfate hemihydrate/mineralized collagen for bone tissue engineering: In vitro release and in vivo bone regeneration studies

Biodegradable Chitosan Scaffolds Containing Microspheres As Carriers for Controlled Transforming Growth Factor-Beta1 Delivery for Cartilage Tissue Engineering.

Fabrication of porous PLGA microspheres with BMP-2 releasing polyphosphate-functionalized nano-hydroxyapatite for enhanced bone regeneration

Nanoparticle-modified chitosan-agarose-gelatin scaffold for sustained release of SDF-1 and BMP-2.